WATCH NOW

Listen Now In:

Apple

Spotify

Key Takeaways

• AI-assisted embryo selection gives fertility teams an additional way to evaluate embryos during IVF. It analyzes embryo images for patterns associated with prior outcomes and can add information beyond traditional visual grading.

• AI does not replace the embryologist or fertility physician. Embryo grade, development, age, medical history, genetic-testing results, laboratory experience, and the individual IVF cycle still matter.

• AI may be most useful when several embryos appear similar. When there is only one embryo available, ranking is less relevant; when several embryos are available, additional information may help determine which embryo to transfer first.

• AI embryo assessment and PGT-A answer different questions. PGT-A evaluates chromosome number from biopsied embryo cells, while AI image analysis evaluates visual patterns. AI should not be presented as a substitute for genetic testing.

• Clinical validation matters. Because AI can function as a “black box,” patients should ask what outcomes the algorithm predicts, how it was validated, and how its score is incorporated into the clinic's final embryo-selection decision.

What is AI embryo selection in IVF? AI embryo selection uses computer algorithms to analyze embryo images and identify visual patterns associated with previous treatment outcomes. The resulting score may help embryologists and fertility physicians rank embryos when deciding which embryo to transfer first. AI-assisted embryo assessment complements traditional embryo grading and clinical information; it does not replace the embryologist, physician, or PGT-A.

Embryo selection is an important part of IVF when more than one embryo is available for transfer. Traditionally, embryologists have evaluated embryos based on their development, blastocyst expansion, and cell appearance, then assigned grades that help fertility teams decide which embryo may be transferred first.

This article explores how artificial intelligence is beginning to add another layer of information to that process.

EmbryoPredict, the technology discussed with reproductive endocrinologist Dr. Eduardo Hariton, analyzes embryo images and compares their visual patterns with data learned from previous embryo images and outcomes. It then provides a score that can be considered alongside traditional embryo grading and the rest of the patient's clinical information.

The important distinction is that AI does not make the decision alone. Age, medical history, embryo development, embryo grade, genetic-testing results when available, and the laboratory team's experience remain relevant.

AI may be particularly useful when several embryos appear similar and clinicians are deciding which one to prioritize for transfer. The article reports that a randomized controlled trial involving more than 400 patients found an approximately 5% overall improvement with AI-assisted selection, with larger effects reported in some groups, including older patients and those who had not undergone preimplantation genetic testing. Before publication, the exact endpoint and whether that “5%” means an absolute or relative improvement should be made explicit.

The article also distinguishes AI embryo assessment from PGT-A. PGT-A analyzes biopsied cells to assess chromosome number. AI analyzes an embryo image for visual patterns associated with prior outcomes. These approaches therefore provide different information, and image-based AI should not be described as a replacement for genetic testing.

The limitations of AI matter too. Algorithms may identify patterns that the human eye cannot readily recognize, but they may not be able to explain exactly why a particular embryo received a particular score. That makes independent validation, high-quality clinical research, and appropriate physician and embryologist oversight essential.

The larger message is not that AI should choose an embryo for you. It is that AI may provide another piece of clinically useful information while patients, physicians, and embryologists remain responsible for making an informed treatment decision.

Turn More Embryo Data Into Better Questions

AI can add another number to an already complicated IVF journey. What matters is understanding what that number means, what it does not tell you, and how your clinic uses it alongside embryo grading, genetic testing, and your individual treatment history.

Before making decisions about embryo testing or transfer, prepare the questions that will help you understand your clinic's recommendations and participate more confidently in your IVF plan.

Explore Fertility Preparation

Frequently Asked Questions - FAQs

What is AI embryo selection in IVF?

AI embryo selection uses computer algorithms to analyze embryo images and identify visual patterns associated with outcomes in prior data. The resulting score may help embryologists and fertility physicians rank embryos when deciding which embryo to consider for transfer first.

Does AI choose which embryo will be transferred?

No. AI provides additional information, but the final embryo-selection decision remains clinical. Embryologists and fertility physicians may also consider embryo development, traditional grading, age, medical history, genetic-testing results when available, previous treatment history, and laboratory experience.

How is AI embryo assessment different from traditional embryo grading?

Traditional embryo grading relies on embryologists evaluating features such as blastocyst development, expansion, and cell appearance. AI analyzes digital embryo images for patterns learned from larger datasets and produces an additional score or ranking. The two approaches can be used together rather than treating one as a replacement for the other.

When might AI embryo selection be most useful?

AI ranking may be more useful when several embryos appear reasonably similar and the fertility team needs additional information to help decide which embryo to prioritize. When only one embryo is available for transfer, ranking multiple embryos is less relevant.

Is AI embryo selection the same as PGT-A?

No. PGT-A and AI image analysis answer different questions. PGT-A evaluates chromosome number using cells biopsied from an embryo, while image-based AI analyzes visual characteristics of the embryo. An AI score should not be presented as a replacement for genetic testing.

Can AI embryo selection predict whether an embryo will implant?

AI systems may be developed to estimate the likelihood of particular outcomes based on patterns in prior data, but an AI score cannot guarantee implantation, pregnancy, or live birth. Embryo transfer outcomes depend on multiple embryo, patient, uterine, laboratory, and treatment factors.

What should patients ask their fertility clinic about AI embryo selection?

Ask what outcome the algorithm is designed to predict, what population it was validated in, whether the evidence comes from prospective or randomized studies, how accurate or useful the score is in patients like you, and how much weight the clinic gives the AI result compared with embryo grading, PGT-A, and embryologist judgment.

Why does clinical validation matter for fertility AI?

An algorithm may generate a precise-looking score without making its reasoning obvious to patients or clinicians. Independent validation and high-quality clinical studies help determine whether the system performs consistently and whether using its score actually improves a clinically meaningful outcome rather than simply producing another measurement.

Conclusion

Artificial intelligence is beginning to change how fertility clinics use information they are already collecting.

Embryo images have always helped embryologists evaluate development. AI may allow those images to be analyzed in additional ways, identifying patterns that are difficult for the human eye to quantify and providing another data point when several embryos are being considered for transfer.

But more data does not eliminate the need for expertise.

An embryo's AI score does not replace its developmental history, genetic-testing information, traditional grading, the laboratory's experience, or the physician's understanding of the individual patient.

It also does not guarantee implantation or pregnancy.

The most useful role for AI is therefore not to take embryo-selection decisions away from fertility professionals or patients. It is to add potentially useful information to a decision that remains clinical and individualized.

As this technology becomes more common, patients should feel comfortable asking how it works, what outcome it predicts, how it has been validated, and how much weight their clinic gives the score.

Better technology is most useful when it leads to better-informed conversations.